OncoZenge is a Swedish pharmaceutical company founded in 2020 through a collaboration between Moberg Pharma AB and leading clinics from Hvidovre Hospital in Denmark.Our vision is to radically improve the quality of life for patients with severe oral pain, for example caused by radiation therapy or chemotherapy for cancer.
Oncozenge develops better products for supportive care of cancer patients. In the near future, we will fo...
OncoZenge is a Swedish pharmaceutical company founded in 2020 through a collaboration between Moberg Pharma AB and leading clinics from Hvidovre Hospital in Denmark.Our vision is to radically improve the quality of life for patients with severe oral pain, for example caused by radiation therapy or chemotherapy for cancer.
Oncozenge develops better products for supportive care of cancer patients. In the near future, we will focus on preparing a phase 3 study for BupiZenge®. This after strong phase 2 results which showed that the pain level in the patients decreased by 50% compared to standard treatment.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.